MyMD Pharmaceuticals (MYMD) Competitors $1.34 -0.02 (-1.47%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends MYMD vs. FREQ, NKGN, WENA, SNSE, JAGX, IMNN, AWH, TLPH, TSBX, and PHXMShould you be buying MyMD Pharmaceuticals stock or one of its competitors? The main competitors of MyMD Pharmaceuticals include Frequency Therapeutics (FREQ), NKGen Biotech (NKGN), ANEW Medical (WENA), Sensei Biotherapeutics (SNSE), Jaguar Health (JAGX), Imunon (IMNN), Aspira Women's Health (AWH), Talphera (TLPH), Turnstone Biologics (TSBX), and PHAXIAM Therapeutics (PHXM). These companies are all part of the "medical" sector. MyMD Pharmaceuticals vs. Frequency Therapeutics NKGen Biotech ANEW Medical Sensei Biotherapeutics Jaguar Health Imunon Aspira Women's Health Talphera Turnstone Biologics PHAXIAM Therapeutics MyMD Pharmaceuticals (NASDAQ:MYMD) and Frequency Therapeutics (NASDAQ:FREQ) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, valuation, community ranking, institutional ownership, earnings, profitability and risk. Does the media refer more to MYMD or FREQ? In the previous week, Frequency Therapeutics had 1 more articles in the media than MyMD Pharmaceuticals. MarketBeat recorded 1 mentions for Frequency Therapeutics and 0 mentions for MyMD Pharmaceuticals. MyMD Pharmaceuticals' average media sentiment score of 0.00 equaled Frequency Therapeutics'average media sentiment score. Company Overall Sentiment MyMD Pharmaceuticals Neutral Frequency Therapeutics Neutral Which has stronger valuation & earnings, MYMD or FREQ? MyMD Pharmaceuticals has higher earnings, but lower revenue than Frequency Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMyMD PharmaceuticalsN/AN/A-$4MN/AN/AFrequency Therapeutics$14.07M0.78-$81.58M-$1.89-0.16 Do institutionals & insiders believe in MYMD or FREQ? 9.6% of MyMD Pharmaceuticals shares are owned by institutional investors. Comparatively, 13.2% of Frequency Therapeutics shares are owned by institutional investors. 2.1% of MyMD Pharmaceuticals shares are owned by company insiders. Comparatively, 16.8% of Frequency Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the MarketBeat Community favor MYMD or FREQ? Frequency Therapeutics received 59 more outperform votes than MyMD Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformMyMD PharmaceuticalsN/AN/AFrequency TherapeuticsOutperform Votes5960.20% Underperform Votes3939.80% Is MYMD or FREQ more profitable? Frequency Therapeutics' return on equity of -107.67% beat MyMD Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets MyMD PharmaceuticalsN/A -179.05% -108.14% Frequency Therapeutics N/A -107.67%-61.40% Which has more volatility & risk, MYMD or FREQ? MyMD Pharmaceuticals has a beta of 2.15, meaning that its share price is 115% more volatile than the S&P 500. Comparatively, Frequency Therapeutics has a beta of 0.84, meaning that its share price is 16% less volatile than the S&P 500. SummaryFrequency Therapeutics beats MyMD Pharmaceuticals on 7 of the 9 factors compared between the two stocks. Ad WealthPressThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here Get MyMD Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MYMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MYMD vs. The Competition Export to ExcelMetricMyMD PharmaceuticalsDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.18M$2.28B$5.23B$8.84BDividend YieldN/A0.75%5.53%4.08%P/E RatioN/A5.0392.7717.55Price / SalesN/A50.561,238.1291.99Price / CashN/A14.9841.4236.93Price / Book0.193.317.236.54Net Income-$4M$29.98M$119.89M$226.15M7 Day Performance12.08%4.68%2.14%3.77%1 Month Performance-19.76%-8.81%-2.23%4.46%1 Year Performance-85.50%-15.67%32.63%27.57% MyMD Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MYMDMyMD PharmaceuticalsN/A$1.34-1.5%N/A-84.7%$3.18MN/A0.009Gap UpFREQFrequency TherapeuticsN/A$0.30flatN/A+0.0%$10.94M$14.07M-0.1646Gap DownNKGNNKGen BiotechN/A$0.36+7.7%N/A-87.7%$12.85M$80,000.00-0.07N/AWENAANEW MedicalN/A$0.73-0.5%N/AN/A$12.51MN/A0.00N/AGap UpSNSESensei Biotherapeutics4.8191 of 5 stars$0.50+2.6%$4.33+773.0%-20.6%$12.48MN/A-0.4140Gap DownJAGXJaguar Health0.6683 of 5 stars$1.05+6.5%N/A-94.9%$12.37M$10.48M0.0050News CoverageIMNNImunon2.0506 of 5 stars$0.80+15.9%$12.00+1,393.7%-8.8%$11.65M$500,000.00-0.3733AWHAspira Women's Health1.4316 of 5 stars$0.72-3.7%$4.40+511.1%-76.4%$11.56M$9.15M0.00110Analyst ForecastGap DownTLPHTalphera2.2557 of 5 stars$0.68-3.5%$4.50+566.7%N/A$11.50M$281,000.00-1.0119Positive NewsGap DownTSBXTurnstone Biologics2.9545 of 5 stars$0.48+2.2%$2.13+342.7%-80.7%$11.10M$19.31M-0.1482PHXMPHAXIAM TherapeuticsN/A$3.10flatN/AN/A$10.58M$32.66M0.0049 Related Companies and Tools Related Companies FREQ Alternatives NKGN Alternatives WENA Alternatives SNSE Alternatives JAGX Alternatives IMNN Alternatives AWH Alternatives TLPH Alternatives TSBX Alternatives PHXM Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MYMD) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MyMD Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MyMD Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MYMD Stock Alerts